Eli Lilly

New Business

Meow or never: China’s pudgy pets spark race for weight-loss drugs

Irina Zhou’s five-year-old cat has gained about a kilogram every year for the past three years. She knows the extra…

Read More »
New Business

Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO

The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28…

Read More »
New Business

China vital to Insilico’s plan to build biotech’s AI ‘Einstein’ for drug discovery

“Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose…

Read More »
New Business

China’s new drug insurance: lifeline for patients or squeeze on big pharmaceutical firms?

Mainland China’s 17 million Alzheimer’s patients can, for the first time, pay less out of pocket for a costly drug…

Read More »
New Business

From chips to noodles: the newcomers testing Hong Kong’s buoyant IPO market

Hong Kong’s booming fundraising market is set for another busy week, with four companies scheduled to debut this week and…

Read More »
New Business

Pfizer’s Metsera acquisition to spur Chinese search for next-generation weight-loss drugs

American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…

Read More »
New Business

China has 60 drugs under trial to rival Ozempic in US$150 billion weight-loss market

When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…

Read More »
New Business

‘China’s Ozempic’ may vie with Eli Lilly, Novo Nordisk for global weight-loss drug market

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…

Read More »
Back to top button